The U.S. Department of Health and Human Services (HHS) initiated a review of its recommendation for annual influenza vaccinations in children, shifting the approach to a case-by-case decision between parents and healthcare providers. This change was partly based on an assessment that noted a lack of randomized controlled trials demonstrating the vaccine's efficacy in pediatric populations, particularly in younger children.
However, a federal court has since blocked the HHS's revised recommendation following a lawsuit filed by public health organizations, thus keeping the prior recommendation in place. The legal case is ongoing.
Earlier this year, President Donald Trump issued an executive order instructing the government to consider a recent HHS assessment as a key resource and to re-evaluate the established childhood vaccination schedule. This assessment, which highlighted that much of the recent evidence supporting annual flu shots for children comes from observational studies rather than randomized trials, suggests that the evidence base for their effectiveness in this age group is limited. While some experts contend that the evidence, including numerous clinical trials, is more robust than depicted in the assessment, they acknowledge that observational studies on annual flu shots can be subject to various statistical biases.